Follow-on formula in the prevention of iron deficiency: a multicentre study

D G Gill1, S Vincent, D S Segal

  • 1Children's Hospital, Dublin, Ireland.

Insights

Iron-fortified formula effectively prevents iron deficiency in infants. This study found iron-fortified formula significantly improved iron status markers compared to non-fortified formula and cow's milk in 6-month-old infants.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Hematology

Background:

  • Iron deficiency is a significant concern in infants.
  • Infant feeding practices, including formula and cow's milk, can impact iron status.

Purpose of the Study:

  • To evaluate the efficacy of iron-fortified formula in preventing iron deficiency in infants.
  • To compare iron status between infants receiving iron-fortified formula, non-fortified formula, and cow's milk.

Main Methods:

  • A randomized controlled trial involving 406 six-month-old infants in the UK and Ireland.
  • Infants were assigned to receive iron-fortified or non-fortified formula for 9 months.
  • Hematological indices and iron status were assessed at 6, 9-10, and 15 months.

Main Results:

  • No significant differences in growth parameters (weight, head circumference, length) were observed between groups.
  • Infants fed iron-fortified formula showed significantly better iron status (hemoglobin, serum ferritin) at 15 months compared to non-fortified formula and cow's milk.
  • Lower rates of iron deficiency were observed in infants receiving iron-fortified formula (6% for serum ferritin < 10 microg/l) compared to non-fortified formula (22%) and cow's milk (43%).

Conclusions:

  • Follow-on formula is an effective way to prevent iron deficiency in vulnerable infants.
  • Iron-fortified formula significantly improves iron status in infants compared to non-fortified options and cow's milk.
  • Adequate iron fortification in infant formula is crucial for preventing iron deficiency anemia.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...